Company Monitoring Page for Acorda-Therapeutics

latest headlines for company on cafepharma

FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
Xconomy
Tue, 08/29/17 - 09:32 am
Tags:
FDA, Acorda Therapeutics, Parkinson's Disease, Inbrija
Bass Battled U.S. Drug Patents and Prices But Lost to ‘Cabal’
Bloomberg
Mon, 04/10/17 - 10:06 am
Tags:
Kyle Bass, patents, drug pricing, AMPYRA, Acorda Therapeutics, multiple sclerosis
Acorda is shifting into survival mode. And it’s going to start by axing more than 100 staffers.
Endpoints
Wed, 04/5/17 - 12:05 pm
Tags:
Acorda Therapeutics, layoffs, AMPYRA
Patent decision puts 95% of Acorda revenue at risk
BioPharma Dive
Tue, 04/4/17 - 07:23 pm
Tags:
Acorda Therapeutics, patents, AMPYRA, multiple sclerosis, MS
Acorda plans NDA for inhaled Parkinson’s drug after touting long-term safety data
Mass Device
Sat, 04/1/17 - 08:03 am
Tags:
Acorda Therapeutics, Parkinson's Disease, CVT-301, Levodopa
Acorda reports 4Q loss
Yahoo/AP
Tue, 02/14/17 - 12:08 pm
Tags:
Acorda Therapeutics, earnings
Acorda stock surges 9% after positive late-stage clinical trial results for Parkinson's drug
Marketwatch
Thu, 02/9/17 - 10:49 am
Tags:
Acorda Therapeutics, clinical trials, CVT-301, Parkinson's Disease
Trial miss derails Acorda's Ampyra plans
BioPharma Dive
Tue, 11/22/16 - 11:37 am
Tags:
Acorda Therapeutics, AMPYRA, stroke
Acorda Stroke Study Fails, Dampening Revenue Growth Plans
TheStreet.com
Mon, 11/21/16 - 11:28 am
Tags:
Acorda Therapeutics, AMPYRA, stroke
3 Best Biotech Stocks of the 21st Century (So Far)
Motley Fool
Sun, 11/6/16 - 12:22 pm
Tags:
biotech, Acorda Therapeutics, Gilead Sciences, Celgene
Acorda reports 3Q loss
Yahoo/AP
Thu, 10/27/16 - 09:18 am
Tags:
Acorda Therapeutics, earnings
Acorda misses 4Q profit forecasts
Yahoo/AP
Thu, 02/11/16 - 09:05 pm
Tags:
Acorda Therapeutics, earnings
Acorda bags PhIII Parkinson's drug in $363M Biotie buyout
Fierce Biotech
Tue, 01/19/16 - 08:20 am
Tags:
Acorda Therapeutics, Parkinson's Disease, BioTie Therapies, M&A, tozadenant
Biogen Who Can Acquire It And Who It Can Acquire
Bidness, ETC
Mon, 11/16/15 - 10:42 am
Tags:
Biogen, M&A, Pfizer, Allergan, Roche, Merck, Acorda Therapeutics
Acorda tops Street 3Q forecasts
Yahoo/AP
Thu, 10/22/15 - 09:42 am
Tags:
earnings, Acorda Therapeutics
Bass Vows to Keep Fighting U.S. Drug Patents After Setbacks
Bloomberg
Thu, 09/3/15 - 06:34 pm
Tags:
Kyle Bass, patents, Biogen, Acorda Therapeutics
Biogen patent survives challenge by hedge fund manager Kyle Bass
Yahoo/Reuters
Wed, 09/2/15 - 05:14 pm
Tags:
Kyle Bass, Biogen, patents, Acorda Therapeutics, Tecfidera
3 Biotech Stocks Bucking the Stock Market Crash
Motley Fool
Sat, 08/29/15 - 09:00 am
Tags:
biotech, Lexicon Pharmaceuticals, La Jolla Pharmaceutical, Acorda Therapeutics
Hedge fund manager Kyle Bass loses first challenges to pharma patents
Yahoo/Reuters
Tue, 08/25/15 - 08:37 am
Tags:
patents, AMPYRA, Kyle Bass, Acorda Therapeutics, MS, multiple sclerosis
Acorda beats Street 4Q forecasts
Yahoo/AP
Thu, 02/12/15 - 09:31 am
Tags:
Acorda Therapeutics, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.